Adult T cell leukemia (ATL) [1] patients display several peculiar clinical features including skin rash, hypercalce-mia and rarely monoclonal gammopathy [2]. We recently encountered a patient with ATL who developed monoclonal gammopathy in the course of chemotherapy. We discuss the possible causes of monoclonal gammopathy in this patient. The patient was a 58-year-old male who was admitted to our clinic with lymphadenopathy in May 1988. Clinical and hematologic findings on admission are shown in table 1. Electrophoretic analysis of serum protein did not reveal an M component. Chest X-ray showed bilateral pulmonary infiltrates, and transbronchial lung biopsy was therefore performed, which identified Pneumocystis carinii organisms. The diagnosis of Pneumocystis carinii pneumonia was made, and he was treated with pentamidine isethionate and sulfamethoxazole trimethoprim. Combination chemotherapy using vincristine, cyclophosphamide and adriamycin for ATL was also started ( fig. 1) . Although chemotherapy was continued, his pneumonia resolved completely. ATL cell count decreased gradually, and a partial remission was obtained. After several days of intramuscular injection of α-interferon (α-IFN) for consolidation chemotherapy, skin eruption and fever developed. Herpes zoster was diagnosed, and he was treated with acyclovir, resulting in improvement. Serum electro-phoresis showed an abnormal peak in the gamma globulin area. The peak gradually increased as shown in figure 1 , and IgG-kappa monoclonal immunoglobulin was detected by immunoelectrophoresis (IgG 3,362 mg/dl; IgA 180.0 mg/dl; IgM 271.5 mg/dl). Table 1 . Clinical and hematologic findings
Since this patient had a complicated presentation with Pneumocystis carinii pneumonia on admission, his prognosis was thought to be quite poor. However, pentamidine isethionate and sulfamethoxazole trimethoprim had a remarkable effect on the pneumonia in spite of simultaneous initiation of chemotherapy for ATL, and a partial remission was obtained. He developed herpes zoster infection after α-IFN therapy, and M protein was detected shortly after.
Monoclonal gammopathy is rarely associated with ATL. It has been reported that monoclonal gammopathy occurs in ATL as a result of the functional activity of ATL cells [2] . Since ATL cells constitutively express interleu-kin-2 (IL-2) receptor and show activated mature helper/ inducer T cell phenotype, it seems likely that they secrete various lymphokines, similarly to normal activated T lymphocytes. It has been demonstrated that fresh ATL cells produce lymphokines, such as IL-1, parathyroid hormone-related protein, transforming growth factor-ß, and B cell VCR ↓ CTX ↓ Treatment A¤R ↓ VDS ↓ ↓ ACNU ↓ ↓ ↓ ↓ Acyclovir ↓cc-IFN↓l·l↓ ↓VP-16 ↓∏ ↓ ACR ↓J‚↓ ↓↓ï i↓ï Fig. 1 . Clinical course, treatment regimen and cellulose-acetate membrane electropho-resis. An abnormal peak detected for the first time in mid-August, 1988 gradually increased. VCR = Vincristine; CTX = cyclo-phosphamide; ADR = adriamycin. differentiation factor (BCDF) in vitro [3] [4] [5] [6] . These findings suggest that ATL cells also produce lymphokines in vivo, which may complicate the clinical features of ATL. Recent studies have revealed that three lymphokines, IL-4, IL-5 and IL-6, are involved in the activation and differentiation of B cells [7] [8] [9] . Since it has been shown that ATL cells secrete BCDF, the rare occurrence of monoclonal gammopathy in ATL patients may be the result of continuous stimulation of B cells by BCDF secreted from ATL cells [6] , although in this case we were not able to examine lymphokine production. To our knowledge, this is the first paper to report the development of monoclonal gammopathy in an ATL patient during the course of chemotherapy.
